Teva Pharma (TEVA) PT Raised to $74 at Maxim Group on Deal for Allergan's Generic Drug Business
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 40.21 -0.41 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.62 | 52 Week High | $66.55 | |||
| Open | $40.20 | 52 Week Low | $37.82 | |||
| Day High | $40.45 | P/E | N/A | |||
| Day Low | $39.58 | EPS | $0.00 | |||
| Volume | 4,068,728 | |||||
